FDA Import Refusal 799-8770230-5/21/1 — NOVO NORDISK
The FDA refused shipment 799-8770230-5/21/1 from NOVO NORDISK (Canada) on Jan 16, 2024. The refused product falls under Drugs and Biologics — INSULIN (INJ) (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jan 16, 2024
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY17 INSULIN (INJ) (ANTI-DIABETIC)
- Charges
- 75